Brief: Pliant Therapeutics Gets Orphan Designation From European Medicines Agency For PLN-74809

Pliant Therapeutics

15/12/2022 13:37

Dec 15 (Reuters) - Pliant Therapeutics Inc  PLRX.O :
    * PLIANT THERAPEUTICS RECEIVES ORPHAN DESIGNATION FROM THE
EUROPEAN MEDICINES AGENCY FOR BEXOTEGRAST (PLN-74809) FOR THE
TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS
    * PLIANT THERAPEUTICS INC - ANTICIPATES TOPLINE 12-WEEK DATA
FROM
320 MG COHORT OF PATIENTS WITH IPF, IN Q1 OF 2023

Source text for Eikon:  ID:nGNX85B7nc 
Further company coverage:  PLRX.O 
 ((Reuters.Briefs@thomsonreuters.com;))